Antibodies against cyclic citrullinated peptide in Japanese psoriatic arthritis patients

Journal of Dermatology

Volumn 37, Issue 4, 2010, Pages 339-345

  Maejima, Hideki ^a   Aki, Ryouichi ^a   Watarai, Akira ^a   Shirai, Kyoumi ^a   Hamada, Yuko ^a   Katsuoka, Kensei ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclic citrullinated peptide antibody; Human leukocyte antigen DRB104; Polyarthritis; Psoriatic arthritis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD45 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA DR ANTIGEN; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; ANTIBODY DETECTION; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; JAPAN; LABORATORY DIAGNOSIS; MALE; PREDICTION; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RADIODIAGNOSIS; RADIOGRAPHY; SKIN ULCER;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; BIOLOGICAL MARKERS; EPITOPES; FEMALE; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; SEVERITY OF ILLNESS INDEX;

EID: 77950294850     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00814.x     Document Type: Article

References (23)

1. Nienhuis RLF, Mandema E. A new serum factor in patients with rheumatoid arthritis, the antiperinuclear factor. Ann Rheum Dis 1964 23 : 302 305.
2. Sebbag M, Simon M, Vincent C, Masson Bessiere C, Girbal E, Durieux JJ. The antiperinuclear factor and the so-called anti-keratin antibodies are the same rheumatoid arthritis-specific antibodies. J Clin Invest 1995 95 : 2672 2679.
3. Schellekens GA, De Jong BA, Van den Hoogen FH, Van de Putte LB, Van Venroojj WJ. Citrulline is an essential constituent of antigenic determinants recognised by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998 101 : 273 281.
4. Kroot E-JA, De Jong BA, Van Leeuwen MA et al. The prognostic value of anti-citrullinated peptide antibody in patients with recent onset rheumatoid arthritis. Arthritis Rheum 2000 43 : 1831 1835.
5. Schellekens GA, Visser H, De Jong BA, Van den Hoogen FH, Hazes JMW, Breedveld FC. The diagnostic properties of rheumatoid arthritis antibodies recognising a cyclic citrullinated peptide. Arthritis Rheum 2000 43 : 155 163.
6. Goldbach-Mansky R, Lee J, McCoy A et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000 2 : 236 243.
7. Bogliolo L, Alpini C, Caporali R, Scire CA, Moratti R, Montecucco C. Antibodies to cyclic citrullinated peptides in psoriatic arthritis. J Rheumatol 2005 32 : 511 515.
8. Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology 2005 44 : 1056 1060.
9. Vander Cruyssen B, Hoffman IEA, Zmierczak H et al. Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis 2005 64 : 1145 1149.
10. Alenius GM, Berglin E, Rantapaa Dahlqvist S. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without manifestations of joint inflammation. Ann Rheum Dis 2006 65 : 398 400.
11. Inanc N, Dalkilic E, Kamali S et al. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol 2007 26 : 17 23.
12. Candia L, Marquez J, Gonzalez C et al. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. J Clin Rheumatol 2006 12 : 226 229.
13. Shibata S, Tada Y, Komine M et al. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis. J Dermatol Sci 2009 53 : 34 39.
14. Taylor WJ, Gladman DD, Helliwell PS et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006 54 : 2665 2673.
15. Rothschild BM, Pingitore C, Eaton M. Dactylitis: implication for clinical practice. Semin Arthritis Rheum 1998 28 : 41 47.
16. Helliwell PS, Porter G, Taylor WJ, for The CASPAR Study Group. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 2007 66 : 113 117.
17. Nielen MMJ, Van der Horst AR, Van Schaardenburg D et al. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 2004 64 : 1199 1204.
18. Masson-Bessiere C, Sebbag M, Durieux JJ et al. In the rheumatoid pannus, antifilaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000 119 : 544 552.
19. Reparon-Schuijt CC, Van Esch WJ, Van Kooten C et al. Secretion of anti- citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 2001 44 : 41 47.
20. Capsi D, Anouk M, Golan I et al. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis Arthritis Rheum 2006 55 : 53 56.
21. Zendman AJ, Vossenaar ER, Van Venrooij WJ. Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis. Autoimmunity 2004 37 : 295 299.
22. Vossenaar ER, Nijenhuis S, Helsen MM et al. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 2003 48 : 2489 2500.
23. Arnett FC, Edworthy SM, Bloch DA et al. The American association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 31 : 315 324.